Bree Foster, PhD
Bree Foster is a science writer at Drug Discovery News with over 2 years of experience at Technology Networks, Drug Discovery News, and other scientific marketing agencies. She holds a PhD in comparative and functional genomics from the University of Liverpool and enjoys crafting compelling stories for science.
Articles by Bree Foster, PhD
| 5 min read
Advances in high-throughput experimentation and machine learning are helping researchers map how gut microbes influence drug response and health outcomes.
| 4 min read
Scientists have developed a new CAR-T manufacturing method using a multi-cytokine scaffold that produces longer-lived immune cells capable of self-renewal.
| 4 min read
A large long-term study in women shows a simple blood test can identify who is most at risk of developing dementia decades before memory problems appear.
| 6 min read
Fit-for-purpose analytics like mass photometry give teams the confidence to refine processes before scaling to GMP-compliant production.
| 4 min read
A new study shows how specific gut bacteria work with diet to trigger fat browning in mice, revealing potential pathways for future metabolic therapies.
| 5 min read
Ireland’s model for advanced therapy manufacturing integrates academic research, workforce development, and regulatory bodies to streamline the production of complex biologics.
| 8 min read
Live-cell assays using BRET offer a sensitive and scalable approach for studying small molecule and biologic interactions in real time.
| 4 min read
A new bacterial platform can produce millions of stabilized peptides in a single experiment, accelerating the search for therapies against hard-to-drug targets.
| 4 min read
Machine learning helps translate complex DNA fragment patterns into disease-specific signatures, offering a new path for early detection.
| 4 min read
Neflamapimod shows promise in slowing ALS by targeting protein clumps and restoring nerve cell function.
| 4 min read
Wake Forest researchers have reprogrammed macrophages to target metastatic tumors in the brain, offering a potential new approach where conventional therapies struggle.
| 4 min read
Researchers uncover how microbes targeting the colon’s mucus may explain treatment-resistant constipation in Parkinson’s disease and other patients.
